Literature DB >> 31753115

Pathology of Melanoma.

Asmita Chopra1, Rohit Sharma2, Uma N M Rao3.   

Abstract

Melanoma is an aggressive malignancy arising from melanocytes in the skin and rarely in extracutaneous sites. The understanding of pathology of melanoma has evolved over the years, with the initial classifications based on the clinical and microscopic features to the current use of immunohistochemistry and genetic sequencing. The depth of invasion and lymph node metastasis are still the most important prognostic features of melanoma. Other important prognostic features include ulceration, lymphovascular invasion, mitosis, and tumor-infiltrating lymphocytes. This article reviews the pathology of melanoma and its precursor lesions, along with the recent advances in pathologic diagnosis of melanoma.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Congenital nevus; Cutaneous; Extra-cutaneous; Melanocyte; Melanoma; Pathology; Sentinel node

Mesh:

Year:  2019        PMID: 31753115     DOI: 10.1016/j.suc.2019.09.004

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  10 in total

1.  Artesunate inhibits melanoma progression in vitro via suppressing STAT3 signaling pathway.

Authors:  Mehmet Berköz; Ferbal Özkan-Yılmaz; Arzu Özlüer-Hunt; Mirosław Krośniak; Ömer Türkmen; Duygu Korkmaz; Sıddık Keskin
Journal:  Pharmacol Rep       Date:  2021-02-20       Impact factor: 3.024

2.  LncRNA MALAT1 Promotes the Proliferation, Migration, and Invasion of Melanoma Cells by Downregulating miR-23a.

Authors:  Pan Wang; Liu Hu; Guili Fu; Jingjing Lu; Yuanquan Zheng; Ying Li; Lin Jia
Journal:  Cancer Manag Res       Date:  2020-07-29       Impact factor: 3.989

Review 3.  The Genetic Basis of Dormancy and Awakening in Cutaneous Metastatic Melanoma.

Authors:  Agata Janowska; Michela Iannone; Cristian Fidanzi; Marco Romanelli; Luca Filippi; Marzia Del Re; Manuella Martins; Valentina Dini
Journal:  Cancers (Basel)       Date:  2022-04-23       Impact factor: 6.575

4.  Construction of autophagy prognostic signature and analysis of prospective molecular mechanisms in skin cutaneous melanoma patients.

Authors:  Shian Liao; Juliang He; Chong Liu; Zide Zhang; Hongyu Liao; Zuowei Liao; Chaojie Yu; Jian Guan; Hao Mo; Zhenchao Yuan; Tuo Liang; Zhaojun Lu; Guoyong Xu; Zequn Wang; Jiarui Chen; Jie Jiang; Xinli Zhan
Journal:  Medicine (Baltimore)       Date:  2021-06-04       Impact factor: 1.817

5.  High regional mortality due to malignant melanoma in Eastern Finland may be explained by the increase in aggressive melanoma types.

Authors:  Ville Suhonen; Jaana Rummukainen; Hanna Siiskonen; Arto Mannermaa; Ilkka T Harvima
Journal:  BMC Cancer       Date:  2021-10-29       Impact factor: 4.430

6.  CD103+ T Lymphocyte Count Linked to the Thickness of Invasion on Acral Melanoma without E-Cadherin Involvement.

Authors:  Fauzan Ali Zainal Abidin; Hermin Aminah Usman; Sri Suryanti; Bethy S Hernowo
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-11-24

7.  Macrophage Membrane-Camouflaged shRNA and Doxorubicin: A pH-Dependent Release System for Melanoma Chemo-Immunotherapy.

Authors:  Chengli Yang; Yang Ming; Kai Zhou; Ying Hao; Danrong Hu; Bingyang Chu; Xinlong He; Yun Yang; Zhiyong Qian
Journal:  Research (Wash D C)       Date:  2022-02-08

8.  Malignant Melanoma-Derived Exosomes Induce Endothelial Damage and Glial Activation on a Human BBB Chip Model.

Authors:  Peng Wang; Yunsong Wu; Wenwen Chen; Min Zhang; Jianhua Qin
Journal:  Biosensors (Basel)       Date:  2022-01-31

9.  MPMR: Multi-Scale Feature and Probability Map for Melanoma Recognition.

Authors:  Dong Zhang; Hongcheng Han; Shaoyi Du; Longfei Zhu; Jing Yang; Xijing Wang; Lin Wang; Meifeng Xu
Journal:  Front Med (Lausanne)       Date:  2022-01-05

10.  Cutaneous melanoma incidence, mortality, and survival in Manizales, Colombia: a population-based study.

Authors:  Juan David Rodríguez-Betancourt; Nelson Arias-Ortiz
Journal:  J Int Med Res       Date:  2022-06       Impact factor: 1.573

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.